European Journal of Hospital Pharmacy : Science and Practice
Overview
European Journal of Hospital Pharmacy : Science and Practice is a scientific journal, published by BMJ Publishing Group since 2012 in English. The journal's country of origin is United Kingdom and its primary focus area is pharmacy.
Details
Details
Abbr.
Eur J Hosp Pharm
Publisher
BMJ Publishing Group
Start
2012
End
Continuing
Frequency
Bimonthly
p-ISSN
2047-9956
e-ISSN
2047-9964
Country
United Kingdom
Language
English
Specialty
Pharmacy
Metrics
Metrics
h-index / Ranks: 11552
24
SJR / Ranks: 10993
360
CiteScore / Ranks: 8368
3.10
JIF / Ranks: 5746
1.7
Recent Articles
1.
Kirsch L, Linxweiler H, Thiesen J, Kraemer I
Eur J Hosp Pharm
. 2025 Mar;
PMID: 40049761
Objective: After patent expiry of the bevacizumab originator product, several biosimilars were approved by the European Medicines Agency. In centralised preparation units, product-specific in-use stability data must be considered. Based...
2.
Bryla A, Lorent S, Vervacke A, Scolas G, Alexandre L
Eur J Hosp Pharm
. 2025 Mar;
PMID: 40049760
Background: The introduction of chimeric antigen receptor (CAR)-T cell therapies to the Belgian market represents a major revolution in patient treatment but also poses a challenge for hospitals to adapt....
3.
St-Jean I, Hachemi D, Friciu M, Forest J, Belliveau M, Williamson D, et al.
Eur J Hosp Pharm
. 2025 Mar;
PMID: 40044403
Background: In the context of the opioid epidemic, it is indispensable to reduce the use of opioids and develop new therapeutic alternatives. The combined use of ketamine, lidocaine and dexmedetomidine...
4.
Chen F, Ding H, Liu S, Chen Z, Tang L, Tong T
Eur J Hosp Pharm
. 2025 Mar;
PMID: 40032507
Objective: The primary objective of this study was to evaluate the physical compatibility of ceftazidime-avibactam with selected intravenous antimicrobials during simulated Y-site administration. Methods: Ceftazidime-avibactam (25 mg/mL) was mixed with...
5.
Romagnoli A, Savoia M, Papini G, Caprodossi A, Bartolini F
Eur J Hosp Pharm
. 2025 Feb;
PMID: 40015721
Objective: Achieving glycaemic control is essential to avoid disease progression and diabetes-related complications. Non-adherence and discontinuity in diabetic therapy are major barriers to optimal glycaemic control. The aim of this...
6.
Gallina M, Testagrossa M, Provenzani A
Eur J Hosp Pharm
. 2025 Feb;
PMID: 40015720
Background: Medical errors pose significant risks to patient safety and public health. Automated unit dose drug dispensing systems (UDDSs) have emerged as valuable tools to reduce medication errors while optimising...
7.
8.
Calvo M, Beunza Sola M, Tirapu B, Sarobe Carricas M, Moreno E
Eur J Hosp Pharm
. 2025 Feb;
PMID: 39978959
This clinical case discusses a man between 60 and 70 years old with lung adenocarcinoma who developed a infection. Because it is an intracellular bacterium, we need to start antibiotic...
9.
van den Oever F, Dekker M, Vasbinder E, van Gelder T, Van den Bemt P
Eur J Hosp Pharm
. 2025 Feb;
PMID: 39971482
Objectives: The goal of this systematic review was to identify and summarise algorithm-managed and pharmacist-managed dosing of erythropoietin stimulating agents (ESA) in patients with renal anaemia and to determine the...
10.